← Eichor
Condition: Urinary System Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Urinary System Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Phase 1 · 82 location(s) · Eli Lilly and Company · NCT05614739DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Phase 1 · 1 location(s) · Monopar Therapeutics · NCT06617169Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT06116019Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT03740256Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161532A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · 286 location(s) · Eli Lilly and Company · NCT07218380Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Phase 2 · 1 location(s) · Henry Ford Health System · NCT06948552SL-28 for Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · Second Life Therapeutics · NCT07341737Development and Analysis of a Stool Bank for Cancer Patients
Phase N/A · 2 location(s) · Persephone Biosciences · NCT04291755Translational Cancer Observational Protocol
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06169436A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT07217171A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · 21 location(s) · Clasp Therapeutics, Inc. · NCT06778863A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 · 85 location(s) · Daiichi Sankyo · NCT06172478Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
NA · 1 location(s) · City of Hope Medical Center · NCT05519878EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410676A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · 30 location(s) · Pfizer · NCT07090499Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Phase N/A · 1 location(s) · Origin Sciences · NCT05102110Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
NA · 1 location(s) · Chinese University of Hong Kong · NCT06926374The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06490211The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Tasca Therapeutics · NCT07030257A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · 62 location(s) · UroGen Pharma Ltd. · NCT06774131Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Phase 2 · 9 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT04617756SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Phase 2 · 1 location(s) · Rutgers, The State University of New Jersey · NCT06822010Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05731622Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary
Phase 2/Phase 3 · 258 location(s) · National Cancer Institute (NCI) · NCT04628767CONFIRM: Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Brigham and Women's Hospital · NCT04368702
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.